We have located links that may give you full text access.
CASE REPORTS
JOURNAL ARTICLE
REVIEW
Midodrine hydrochloride and the treatment of orthostatic hypotension in tetraplegia: two cases and a review of the literature.
Spinal Cord 2000 Februrary
STUDY DESIGN: A report of two cases of orthostatic hypotension in acute tetraplegia that were resistant to classic treatment interventions.
OBJECTIVE: To discuss the use of midodrine hydrochloride for the treatment of orthostatic hypotension in early tetraplegia.
SETTING: Department of Rehabilitation Medicine, The University of Texas Health Science Center at San Antonio, Texas, USA.
METHODS: Presentation of two cases.
RESULTS: Midodrine hydrochloride successfully treated two cases of orthostatic hypotension that had been refractory to classic treatment interventions.
CONCLUSION: Midodrine hydrochloride should be included in the armamentarium of the physician treating orthostatic hypotension in spinal cord injury.
OBJECTIVE: To discuss the use of midodrine hydrochloride for the treatment of orthostatic hypotension in early tetraplegia.
SETTING: Department of Rehabilitation Medicine, The University of Texas Health Science Center at San Antonio, Texas, USA.
METHODS: Presentation of two cases.
RESULTS: Midodrine hydrochloride successfully treated two cases of orthostatic hypotension that had been refractory to classic treatment interventions.
CONCLUSION: Midodrine hydrochloride should be included in the armamentarium of the physician treating orthostatic hypotension in spinal cord injury.
Full text links
Related Resources
Trending Papers
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app